- Home
- ADAG vs PCM Comparison
ADAG vs PCM Comparison
Compare ADAG & PCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ADAG | PCM |
|---|---|---|
| Founded | 2011 | 1993 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.8M | 82.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADAG | PCM |
|---|---|---|
| Price | $1.93 | $6.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 73.7K | 29.1K |
| Earning Date | 08-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.68% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $103,204.00 | N/A |
| Revenue This Year | $6,983.06 | N/A |
| Revenue Next Year | $36.05 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.30 | $6.88 |
| 52 Week High | $3.16 | $10.20 |
Technical Indicators
Market Signals| Indicator | ADAG | PCM |
|---|---|---|
| Relative Strength Index (RSI) | 49.37 | 33.48 |
| Support Level | $1.76 | $6.09 |
| Resistance Level | $1.90 | $6.15 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 53.19 | 0.00 |
Price Performance
Historical ComparisonAbout ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About PCM PCM Fund Inc.
Pcm Fund Inc is a closed-end investment management company. Its investment objective is to seek current income as a primary focus and also capital appreciation. The Fund invests in agency-guaranteed mortgage-backed securities, private-label mortgage-backed securities, high-yield corporate debt securities, and commercial mortgage-backed securities.